NMBio MemberZocere, Inc

Zocere, Inc. is a New Mexico-based biotech company that is developing novel therapeutics for neurological diseases, including stroke, and offering services to other entities developing stroke-related diagnostics and treatments. We have licensed patented technology for a derivative of the brain-specific STEP protein, tyrosine phosphatase, developed at the University of New Mexico. This technology is the foundation for a novel, generation next therapeutic treatment of stroke that shows promise of becoming the first injectable neuroprotectant drug in the market.

Company/Organization Contacts

Wayne Laslie, President & CEO

Email | 505-272-7041


801 University SE
Suite 100
Albuquerque, NM 87106
Member Website»